Skip to main content
Top
Published in: Pituitary 2/2010

01-06-2010 | Case Report

An unusual collision tumor comprising a prolactinoma and a plasmocytoma originating from the sellar region

Authors: Juan Rivera, Synnove Alves, Caterina Chiara Bianchi, Nawal Al-Mutawa, Marie Christine Guiot, Anthony Zeitouni

Published in: Pituitary | Issue 2/2010

Login to get access

Abstract

A 58-year-old previously healthy man presented with diplopia of rapid onset over a few days. Examination demonstrated bilateral sixth and right fourth cranial nerve palsy. MR imaging showed a large sellar mass with significant destruction of the pituitary fossa. Laboratory tests revealed very high serum prolactin (2,483 ng/dl, reference range 3–13 ng/dl). Dopamine agonist therapy was initiated with significant decline in PRL levels; however, nausea, fatigue, and anorexia developed. Within a few weeks the patient developed renal failure and hypercalcemia. Urine protein electrophoresis revealed large free monoclonal kappa peaks while extensive plasmocytosis was evident in bone marrow aspirates. On bone scan numerous lytic lesions were present. A transsphenoidal excisional biopsy was performed which demonstrated two distinct populations of cells, corresponding to a plasma cell tumor and a lactotroph adenoma. Treatment for multiple myeloma was initiated along with radiotherapy for the sellar tumor. Only a few cases of solitary plasmocytomas of the pituitary region have been reported. Few cases of prolactinomas coexisting with other sellar tumors has been described. We discuss in this report possible pathogenic and functional connections between these two tumors. We suggest that in the presence of extensive cranial nerve involvement, atypical imaging findings for a pituitary adenoma and severe hyperprolactinemia, the possibility of a collision tumor should lead the physician to consider excisional tumor biopsy or surgery in addition to dopamine agonist therapy.
Literature
3.
go back to reference Syro LV, Horvath E, Kovacs K (2000) Double adenoma of the pituitary: a somatotroph adenoma colliding with a gonadotroph adenoma. J Endocrinol Invest 23:37–41PubMed Syro LV, Horvath E, Kovacs K (2000) Double adenoma of the pituitary: a somatotroph adenoma colliding with a gonadotroph adenoma. J Endocrinol Invest 23:37–41PubMed
4.
go back to reference Karavitaki N, Scheithauer B, Watt J, Ansorge O, Moschopoulos M, Llaguno A et al (2008) Collision lesions of the sella: co-existence of craniopharyngioma with gonadotroph adenoma and of Rathke’s cleft cyst with corticotroph adenoma. Pituitary 11:317–323. doi:10.1007/s11102-007-0070-6 CrossRefPubMed Karavitaki N, Scheithauer B, Watt J, Ansorge O, Moschopoulos M, Llaguno A et al (2008) Collision lesions of the sella: co-existence of craniopharyngioma with gonadotroph adenoma and of Rathke’s cleft cyst with corticotroph adenoma. Pituitary 11:317–323. doi:10.​1007/​s11102-007-0070-6 CrossRefPubMed
7.
go back to reference Gadó KNG, Hasitz A, Tóth BE, Rimanóczi E, Domján G (2001) Evidence of prolactin immunoreactivity in the bone marrow of untreated multiple myeloma patients. Neuroimmunomodulation 9:95–102. doi:10.1159/000049012 CrossRefPubMed Gadó KNG, Hasitz A, Tóth BE, Rimanóczi E, Domján G (2001) Evidence of prolactin immunoreactivity in the bone marrow of untreated multiple myeloma patients. Neuroimmunomodulation 9:95–102. doi:10.​1159/​000049012 CrossRefPubMed
9.
go back to reference Gadó K, Rimanóczi É, Hasitz Á, Gigler G, Tóth BE, Nagy GM et al (2001) Elevated levels of serum prolactin in patients with advanced multiple myeloma. Neuroimmunomodulation 9:231–236. doi:10.1159/000049031 CrossRefPubMed Gadó K, Rimanóczi É, Hasitz Á, Gigler G, Tóth BE, Nagy GM et al (2001) Elevated levels of serum prolactin in patients with advanced multiple myeloma. Neuroimmunomodulation 9:231–236. doi:10.​1159/​000049031 CrossRefPubMed
10.
go back to reference Gandhi GY, Basu R, Dispenzieri A, Basu A, Montori VM, Brennan MD (2007) Endocrinopathy in POEMS syndrome: the Mayo Clinic experience. Mayo Clin Proc 82:836–842CrossRefPubMed Gandhi GY, Basu R, Dispenzieri A, Basu A, Montori VM, Brennan MD (2007) Endocrinopathy in POEMS syndrome: the Mayo Clinic experience. Mayo Clin Proc 82:836–842CrossRefPubMed
11.
go back to reference Reulecke M, Dumas M, Meier C (1988) Specific antibody activity against neuroendocrine tissue in a case of POEMS syndrome with IgG gammopathy. Neurology 38:614–616PubMed Reulecke M, Dumas M, Meier C (1988) Specific antibody activity against neuroendocrine tissue in a case of POEMS syndrome with IgG gammopathy. Neurology 38:614–616PubMed
13.
go back to reference Losa M, Terreni MR, Tresoldi M, Marcatti M, Campi A, Triulzi F et al (1992) Solitary plasmacytoma of the sphenoid sinus involving the pituitary fossa: a case report and review of the literature. Surg Neurol 35:388–393. doi:10.1016/0090-3019(92)90010-K CrossRef Losa M, Terreni MR, Tresoldi M, Marcatti M, Campi A, Triulzi F et al (1992) Solitary plasmacytoma of the sphenoid sinus involving the pituitary fossa: a case report and review of the literature. Surg Neurol 35:388–393. doi:10.​1016/​0090-3019(92)90010-K CrossRef
14.
go back to reference McLaughlin DM, Gray WJ, Jones FGC, Mirakhur M, McCance DR, Sheridan B et al (2004) Plasmacytoma: an unusual cause of a pituitary mass lesion. A case report and a review of the literature. Pituitary 7:179–181. doi:10.1007/s11102-005-1758-0 CrossRefPubMed McLaughlin DM, Gray WJ, Jones FGC, Mirakhur M, McCance DR, Sheridan B et al (2004) Plasmacytoma: an unusual cause of a pituitary mass lesion. A case report and a review of the literature. Pituitary 7:179–181. doi:10.​1007/​s11102-005-1758-0 CrossRefPubMed
15.
go back to reference Sanchez JA, Rahman S, Strauss RA, Kaye GI (1977) Multiple myeloma masquerading as a pituitary tumor. Arch Pathol Lab Med 101:55–56PubMed Sanchez JA, Rahman S, Strauss RA, Kaye GI (1977) Multiple myeloma masquerading as a pituitary tumor. Arch Pathol Lab Med 101:55–56PubMed
20.
go back to reference Klein B, Zhang XG, Lu ZY, Bataille R (1995) Interleukin-6 in human multiple myeloma. Blood 85:863–872PubMed Klein B, Zhang XG, Lu ZY, Bataille R (1995) Interleukin-6 in human multiple myeloma. Blood 85:863–872PubMed
21.
go back to reference Clevenger CV (2003) Role of prolactin/prolactin receptor signaling in human breast cancer. Breast Dis 18:75–86PubMed Clevenger CV (2003) Role of prolactin/prolactin receptor signaling in human breast cancer. Breast Dis 18:75–86PubMed
Metadata
Title
An unusual collision tumor comprising a prolactinoma and a plasmocytoma originating from the sellar region
Authors
Juan Rivera
Synnove Alves
Caterina Chiara Bianchi
Nawal Al-Mutawa
Marie Christine Guiot
Anthony Zeitouni
Publication date
01-06-2010
Publisher
Springer US
Published in
Pituitary / Issue 2/2010
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-008-0145-z

Other articles of this Issue 2/2010

Pituitary 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine